Jane Buchan

This profile gathers the share dealings of Jane Buchan across 2 companies, led by Globe Life Inc. and Immix Biopharma, Inc. The record holds 6 filings, for trades running from 16 November 2023 to 22 May 2026.

No open-market purchase appears, only 1 sale worth €116k. Besides market trades, the filings include 3 share grants.

On 29 May 2026 came the latest disclosure, a share grant in Immix Biopharma, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.